Hassold Nicole, Wolfschmidt Franziska, Dierks Alexander, Klein Ingo, Bley Thorsten, Kickuth Ralph
Institute of Diagnostic and Interventional Radiology, University of Wuerzburg, Wuerzburg, Germany.
Institute of Diagnostic and Interventional Radiology, University of Wuerzburg, Wuerzburg, Germany.
J Vasc Surg. 2016 Nov;64(5):1373-1383. doi: 10.1016/j.jvs.2016.05.071. Epub 2016 Jul 25.
The purpose of this study was to evaluate the clinical and long-term outcome of patients who underwent covered stent treatment because of late-onset postpancreatectomy hemorrhage in a greater number of patients. A secondary study goal was to compare embolization techniques with covered stents regarding differences in early and late clinical outcome, rebleeding, and vessel patency.
Between December 2008 and June 2015, 27 consecutive patients suffering from major hemorrhage after pancreatic surgery underwent either covered stent placement or embolization of the affected visceral artery. The patients' medical reports and radiologic images were retrospectively reviewed. The main study end point was technical and clinical success, including survival and complications; the secondary end points were perfusion distal to the target vessel and, for covered stent placement, patency of the affected artery.
Covered stent placement was successful in 14 of 16 patients (88%); embolization was successful in 10 of 11 (91%) patients. For the embolization group, the overall 30-day and 1-year survival rate was 70%, and the 1- and 2-year survival rate was 56%; for the covered stent group, these rates were 81% and 74%, respectively. The 30-day patency of the covered stent was 84%, and 1-year patency was 42%; clinically relevant ischemia was observed in two patients. Infarction distal to the embolized vessel occurred in 6 of 11 patients (55%).
Endovascular treatment using either covered stents or embolization techniques is an effective and safe emergency therapy for life-threatening postpancreatectomy hemorrhage with good clinical success rates and long-term results. Covered stent placement preserving vessel patency in the early postoperative phase should be preferred to embolization if it is technically feasible.
本研究旨在评估因晚期胰腺切除术后出血而接受覆膜支架治疗的大量患者的临床及长期预后。次要研究目标是比较栓塞技术与覆膜支架在早期和晚期临床结局、再出血及血管通畅性方面的差异。
2008年12月至2015年6月期间,27例胰腺手术后发生大出血的连续患者接受了覆膜支架置入或受累内脏动脉栓塞治疗。对患者的医学报告和影像学图像进行回顾性分析。主要研究终点为技术和临床成功,包括生存及并发症;次要终点为靶血管远端的灌注情况,对于覆膜支架置入术,还包括受累动脉的通畅情况。
16例患者中有14例(88%)覆膜支架置入成功;11例患者中有10例(91%)栓塞成功。栓塞组的30天和1年总生存率分别为70%,1年和2年生存率为56%;覆膜支架组的相应生存率分别为81%和74%。覆膜支架的30天通畅率为84%,1年通畅率为42%;2例患者出现临床相关缺血。11例患者中有6例(55%)在栓塞血管远端发生梗死。
使用覆膜支架或栓塞技术进行血管内治疗是治疗危及生命的胰腺切除术后出血的一种有效且安全的紧急治疗方法,临床成功率和长期效果良好。如果技术可行,术后早期保留血管通畅的覆膜支架置入术应优于栓塞术